| Market Cap | $2.38B+70.3% |
| Revenue (ttm) | $884.00M |
| Net Income | -$56.10M |
| EPS | -$0.26 |
| Shares Out | 218.31M |
| PE Ratio | n/a |
| Forward PE | 24.18 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 2,387,458 |
| Open | $11.07 |
| Previous Close | $11.23 |
| Day's Range | $10.83 - $11.25 |
| 52-Week Range | $5.37 - $14.26 |
| Beta | 1.86 |
| Analysts | Buy |
| Price Target | $14.00(+28.68%) |
| Earnings Date | Jan 7, 2027 |
About NEOG
Neogen Corporation develops, manufactures, and markets various products and services for food and animal safety in the United States and internationally. It operates through Food Safety and Animal Safety segments. The company offers diagnostic test kits and complementary products to detect dangerous and/or unintended substances in human food and animal feed, such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns. It also provides reagents and test kits used in immunoassay production, forensic and animal toxicology, and life science research; unique colorimetric and chemiluminescent substrates for research use; veterinary instruments and delivery systems under the Ideal and Prima Tech brands; and precision instruments designed for injections, topical and oral administration, artificial insemination, and animal identification for farmers, ranchers, and veterinarian under the Prima Tech brand. In addition, the company offers digestive aids and nutritional supplements; Natural Vitamin E-AD to address vitamin deficiencies in swine, cattle, and sheep; RenaKare; companion animal parasiticides under Provecta brand; BotVax B; EqStim; ImmunoRegulin; companion animal parasiticides under the Provecta brand; rodent and insect control products under the Ramik, CyKill, Havoc, Prozap, SureKill, and StandGuard brands. Further, it markets Uniprim, a veterinary antibiotic; operates sgenomics labs offering DNA genotyping, sequencing, and trait analysis for livestock and companion animals; and provides software systems that help testers to analyze and store results and perform analysis. The company has a strategic collaboration with Hinalea Imaging Corp. to develop digital imaging solutions for food safety and quality inspection. Neogen Corporation was incorporated in 1981 and is headquartered in Lansing, Michigan.
Neogen Corp Stock Analysis — InsiderScore
Neogen Corp scored higher than 38% of companies evaluated by InsiderBuying, and ranked 47th out of 98 stocks in the biotech sector.
Scores are percentile-ranked against every company we scored that day, with extra weight given to the size and conviction of each purchase and the seniority of the buyer.
Insiders at Neogen Corp bought $6.0K of stock across 1 purchase in the last 90 days, the largest of them $6.0K.
The average purchase added about 47% to the buyer's existing holding. Doubling a stake earns full marks here; topping up an already large position earns very little.
Every buyer already held stock, so each purchase is an increase rather than a first position.
This category carries 35% of the Insider Score.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
Analyst consensus
2 firms rating NEOG in the last 3 months, one vote each. Issuer-paid research is not counted.
Next catalysts
- Jan 7, 2027Earnings report
$NEOG stock is featured in our Insider Score Rankings, Congress Trading, and Insider Trades datasets.
→ All Stock ListsCongress Trading
Recent trades of NEOG by members of U.S. Congress
| Donna ShalalaHouse | Sale$1.00K – $15.00K | Jun 24, 2019 |
Recently reported changes in NEOG holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by NEOG's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
NEOG Estimated quarterly lobbying spending
Source: U.S. Senate LDA
NEOG Revenue by Segment or Geography
| Food Safety | $163.20M | 73.25% |
| Animal Safety | $59.60M | 26.75% |
As of: Q3 2026 (Aug 31, 2026) · Source: SEC EDGAR (10-Q)
U.S. Patents
New NEOG patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to NEOG from public contracts
Source: USAspending.gov
Bull Case vs Bear Case
AI-generated from NEOG’s recent data — informational, not investment advice
What’s Behind the Score
News check: Better-than-expected Q3 earnings results drove positive stock movement; upcoming healthcare conference appearance signals management confidence.
Recent Insider Activity
Insider Score Trend Over Time
+42.3 since Sep 19Composite Insider Score (0–100) recomputed on each scoring run from live SEC Form 4 data.
Frequently Asked Questions
ETFs that hold this stock
| NIFE | Direxion Fallen Knives ETF | 1.88% |
| XHE | State Street SPDR S&P Health Care Equipment ETF | 1.43% |
| PSCH | Invesco S&P SmallCap Health Care ETF | 1.33% |
| NBSM | Neuberger Berman Small-Mid Cap ETF | 1.31% |
| PTH | Invesco Dorsey Wright Healthcare Momentum ETF | 0.82% |
| XSMO | Invesco S&P SmallCap Momentum ETF | 0.72% |
| MOO | VanEck Agribusiness ETF | 0.62% |
| SAWS | AAM Sawgrass U.S. Small Cap Quality Growth ETF | 0.54% |
| LITL | Simplify Piper Sandler US Small-Cap PLUS Income ETF | 0.52% |
| FESC | First Eagle Small Cap Equity ETF | 0.46% |
| ACSG | American Century Small Cap Growth Insights ETF | 0.40% |
| TSEE | T. Rowe Price Small Cap ETF | 0.35% |
Weight is the stock’s share of each fund’s holdings.
